MX2010005175A - Oral dispersable tablet. - Google Patents

Oral dispersable tablet.

Info

Publication number
MX2010005175A
MX2010005175A MX2010005175A MX2010005175A MX2010005175A MX 2010005175 A MX2010005175 A MX 2010005175A MX 2010005175 A MX2010005175 A MX 2010005175A MX 2010005175 A MX2010005175 A MX 2010005175A MX 2010005175 A MX2010005175 A MX 2010005175A
Authority
MX
Mexico
Prior art keywords
tablet
oral
dispersable tablet
oral dispersable
amount
Prior art date
Application number
MX2010005175A
Other languages
Spanish (es)
Inventor
Tobias Laich
Thomas Steenpass
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of MX2010005175A publication Critical patent/MX2010005175A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention is directed to an oral disintegratable tablet which exhibits oral disintegratability of not more than 60 seconds. The tablet for oral administration, comprises an effective amount of at least one active agent, an amount of at least 50% (w/w) of a water insoluble parts, a surfactant and a disintegrant, such that said tablet is orally disintegretable or dispersable.
MX2010005175A 2007-12-08 2008-11-25 Oral dispersable tablet. MX2010005175A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07023802 2007-12-08
PCT/EP2008/009968 WO2009071219A2 (en) 2007-12-08 2008-11-25 Oral dispersable tablet

Publications (1)

Publication Number Publication Date
MX2010005175A true MX2010005175A (en) 2010-08-02

Family

ID=40631079

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005175A MX2010005175A (en) 2007-12-08 2008-11-25 Oral dispersable tablet.

Country Status (9)

Country Link
EP (1) EP2231126A2 (en)
JP (2) JP2011506279A (en)
KR (1) KR20100096140A (en)
CN (1) CN101888834A (en)
BR (1) BRPI0820861A2 (en)
MX (1) MX2010005175A (en)
RU (1) RU2010128019A (en)
TW (1) TW200938233A (en)
WO (1) WO2009071219A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012005163A2 (en) * 2009-09-08 2016-05-03 Kyowa Chem Ind Co Ltd antacid and laxative tablet comprising magnesium oxide particles, process for producing an antacid and laxative tablet, and, tablet use
CN101797236B (en) * 2010-03-23 2012-05-23 西南大学 Rivastigmine orally disintegration tablet and preparation method thereof
JP5944378B2 (en) * 2010-04-27 2016-07-05 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ Orally disintegrating tablets containing acarbose
US20110300216A1 (en) * 2010-06-03 2011-12-08 First Eric R Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
JP5750856B2 (en) * 2010-10-04 2015-07-22 ライオン株式会社 Solid pharmaceutical composition and pharmaceutical preparation
KR101237646B1 (en) * 2010-12-09 2013-03-04 주식회사 드림파마 Solid dispersion comprising celecoxib with improved bioavailibity, pharmaceutical composition comprising the solid dispersion, and preparation method of the solid dispersion
FR2968992B1 (en) * 2010-12-16 2013-02-08 Sanofi Aventis ORODISPERSIBLE PHARMACEUTICAL TABLET BASED ON ZOLPIDEM
FR2968995B1 (en) * 2010-12-16 2013-03-22 Sanofi Aventis PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION TO PREVENT MEASUREMENT
TR201100150A2 (en) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Water soluble dosage forms
WO2013115741A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic Pharmaceutical compositions comprising alpha-glucosidase inhibitor
CN102600149B (en) * 2012-02-02 2013-12-04 西藏易明西雅生物医药科技有限公司 Pharmaceutical composition for treating diabetes
WO2015007676A1 (en) * 2013-07-19 2015-01-22 Bayer Pharma Aktiengesellschaft Super quick disintegrating tablet formula for api miglitol
JP5713421B1 (en) 2013-07-19 2015-05-07 株式会社三和化学研究所 Orally disintegrating tablets
CN103877041B (en) * 2014-03-14 2016-07-06 崔书豪 A kind of piroxicam dispersible tablet and preparation method thereof
CA3048952A1 (en) 2016-01-29 2017-08-03 Hikaru Kobayashi Solid preparation, method for producing solid preparation, and method for generating hydrogen
CN105640954B (en) * 2016-02-04 2019-03-05 青岛市海慈医疗集团 It is a kind of to treat dyspeptic Cisapride tablet
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US11786471B2 (en) * 2016-07-11 2023-10-17 Wuhan Ll Science And Technology Development Co. Ltd. Complex disintegrant system for oral solid preparation and oral solid preparation comprising said complex disintegrant system
JP6916184B2 (en) 2016-08-23 2021-08-11 株式会社Ｋｉｔ Formulation manufacturing method
EP3505151A4 (en) 2016-08-23 2020-03-11 Hikaru Kobayashi Hydrogen supply material and production method therefor, and hydrogen supply method
CN107334742B (en) * 2017-08-18 2020-01-31 山东力诺制药有限公司 fluoxetine hydrochloride dispersible tablet and preparation method thereof
EA202090166A1 (en) * 2017-09-28 2020-06-29 Ханми Фарм. Ко., Лтд. PHARMACEUTICAL COMPOSITION, INCLUDING MULTI-COMPONENT SPHEROID FORM TABLET CONTAINING ESOMEPRAZOLE AND ITS PHARMACEUTICAL ACCEPTABLE SALT, AND METHOD FOR PREPARATION
CN110840850B (en) * 2018-07-24 2023-03-17 烟台药物研究所 Celecoxib freeze-dried orally disintegrating tablet with high bioavailability and preparation method thereof
CN109864971B (en) * 2019-04-08 2021-12-17 西安远大德天药业股份有限公司 Granules of lamotrigine solid dispersion and preparation method thereof
CN114224855B (en) * 2021-12-01 2023-11-28 北京悦康科创医药科技股份有限公司 Doxazosin mesylate buccal tablet and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802700A1 (en) * 1998-01-24 1999-07-29 Bayer Ag Preparation of fast-dissolving tablets for controlling blood sugar levels
MXPA04007428A (en) * 2002-02-01 2004-10-11 Pfizer Prod Inc Immediate release dosage forms containing solid drug dispersions.
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
CN1819819B (en) * 2003-05-07 2011-03-09 株式会社三养社 Highly plastic granules for making fast melting tablets
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
US20070196477A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly dissolving tablets comprising low surface area calcium phosphates
US20070196474A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly disintegrating low friability tablets comprising calcium carbonate
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Also Published As

Publication number Publication date
WO2009071219A3 (en) 2009-09-11
KR20100096140A (en) 2010-09-01
JP2015038123A (en) 2015-02-26
RU2010128019A (en) 2012-01-20
JP2011506279A (en) 2011-03-03
CN101888834A (en) 2010-11-17
TW200938233A (en) 2009-09-16
BRPI0820861A2 (en) 2015-06-16
WO2009071219A2 (en) 2009-06-11
EP2231126A2 (en) 2010-09-29

Similar Documents

Publication Publication Date Title
MX2010005175A (en) Oral dispersable tablet.
UA91376C2 (en) Controlled release formulation
WO2008070670A3 (en) Enhanced immediate release formulations of topiramate
MX343358B (en) Ulipristal acetate tablets.
WO2011049706A8 (en) Orally transformable tablets
MX2009009463A (en) Fast-dissolving/disintegrating film preparation having high proportion of active.
MX2007007885A (en) Orally disintegrating pharmaceutical compositions with sensory cue agents.
MA30725B1 (en) ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS
WO2006084164A8 (en) Gastric retention and controlled release delivery system
MX2009004439A (en) Ibuprofen composition.
GB0618879D0 (en) Pharmaceutical compositions
MX2010002735A (en) Titration package for neramexane and its use in the treatment of an inner ear disorder.
WO2010038237A3 (en) Compositions exhibiting delayed transit through the gastrointestinal tract
IL193252A0 (en) N-hydroxyacrylamide compounds
MX2010003439A (en) Pharmaceutical combination of aliskiren and valsartan.
TW200600098A (en) Solid orally ingestible formulations of tetrodotoxin
HUP0401811A2 (en) Medicinal composition improved in solubility in water and process for its preparation
TN2010000135A1 (en) Galenical formulations of organic compounds
PH12017502249A1 (en) Tofacitinib orally disintegrating tablets
RS51211B (en) Use of kappa opioid receptor antagonists-containing compositions for the treatment of dissociative disorders
IS8202A (en) Deramsíklan-fúmarattöflur
JO3239B1 (en) Galenical Formulations of Organic Compounds
WO2006116582A3 (en) Pharmaceutical compositions comprising a substituted benzimidazole, buffering agent and vitamin b12
TR200903548A1 (en) Oral dispersing emoxipine compositions
WO2019016673A3 (en) A stable oral pharmaceutical composition of imatinib

Legal Events

Date Code Title Description
FA Abandonment or withdrawal